GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream…
userSeptember 25, 2024
GEN has signed an important partnership and collaboration agreement with Jaguar Health.…
userMarch 20, 2024
GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238 Ankara,…
userFebruary 22, 2024
As one of Türkiye's fastest-growing pharmaceutical companies, we are pleased to be…
userSeptember 4, 2023
